New ingestible sensor for non-intrusive sleep disorder monitoring developed by MIT and collaborators

A recent Device study reported the effectiveness of an ingestible vitals-monitoring pill (VM pill) to monitor vital signs, including heart and respiratory rate based on a human trial.

FDA OKs Device for Pediatric Kidney Injury Due to Sepsis

The FDA gave the green light to a new device for treating children with acute kidney injury (AKI) due to sepsis or a septic condition

February 24, 2024

Bellerophon’s board approves liquidation plan, leaves Nasdaq after layoffs and trial failures

Bellerophon Therapeutics’ board of directors has approved a plan to liquidate the company and now just needs shareholder approval to dissolve after it let go

October 17, 2023

H5N1 bird flu in U.S. cattle: A wake-up call to action

The recent detection of H5N1 bird flu in U.S. cattle, coupled with reports of a dairy worker contracting the virus, demands a departure from the

April 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.